Study programmes

Xenobiochemistry and Pathobiochemistry

Study program:
Xenobiochemistry and Pathobiochemistry
SP code:
P0916D080023
Study form:
combined
Study type:
doctoral
Standard duration of study in years:
4
Language of instruction:
Czech
Title:
Ph.D.
Title:
No
More details
SP name in English:
Xenobiochemistry and Pathobiochemistry
SP name in Latin:
Xenobiochemia ac biochemia pathologica
SP profile:
academically oriented

SP characteristics

The aim of the study is the preparation for highly qualified research work with deep theoretical and practical knowledge in xenobiochemistry, patobiochemistry, and medical biochemistry and good knowledge in other biochemical sciences and related sciences in the field of pharmacy, biology and medicine. The core of the program is a research project based on experimental laboratory work, the results of which are published internationally and summarized in the dissertation thesis. The study is focused on biochemical disciplines with an emphasis on the interaction of xenobiotics with molecules of the organism, and on the biochemistry of pathological conditions, including clinical-biochemical aspects.
More details
Graduate profile for the public:
Graduates of the DSP Xenobiochemistry and Pathobiochemistry are highly qualified professionals who areversatile and prepared for highly professional work in pharmaceutical, medical and bioanalytical laboratories within medical institutions or companies, for work in laboratories with a general biochemical focus, and for an academic career as a university teacher in the field of biochemical disciplines in pharmacy, medicine and biomedicine. They are prepared to continuously educate themself in these disciplines and to expand their knowledge in line with new findings in the field. They have a detailed knowledge of the full breadth of metabolism, pathobiochemistry and xenobiochemistry and scientific methods in pharmaceutical, medical and biomedical research. They apply this knowledge to experimental work in the laboratory. They are proficient in the preparation of biological models and in procedures to test the biological effects and metabolic fate of substances in vitro and in vivo. They can independently critically evaluate new findings in accordance with the principles of evidence-based medicine, design a scientific experiment to address scientific questions of a biochemical nature, prepare a research grant application, manage a small team, and interpret, discuss and present the results of scientific work.

Related accreditations

Faculty Name of the study program Language of instruction Study form
Lékařská fakulta v Hradci Králové Xenobiochemie a patobiochemie čeština prezenční
Lékařská fakulta v Hradci Králové Xenobiochemistry and Pathobiochemistry angličtina prezenční
Farmaceutická fakulta v Hradci Králové Xenobiochemie a patobiochemie čeština prezenční
Farmaceutická fakulta v Hradci Králové Xenobiochemistry and Pathobiochemistry angličtina prezenční
Lékařská fakulta v Hradci Králové Xenobiochemistry and Pathobiochemistry angličtina kombinovaná
Farmaceutická fakulta v Hradci Králové Xenobiochemistry and Pathobiochemistry angličtina kombinovaná

Teaching provided by

Faculty:
  • Faculty of Medicine in Hradec Králové (LFHK)
  • Faculty of Pharmacy in Hradec Králové (FaF) https://www.faf.cuni.cz
Cooperating institutions:
No
More details
Foreign university joint diploma type:
No
External department:
No

Classification

Area of education:
  • Pharmacy
  • General Medicine and Dentistry

SP structure

Specialisation:
No
Double-curriculum study:
No
Data for persons with disabilities
Contact person for persons with disability:
PhDr. Zděnka Kudláčková, Ph.D.
Further information about the study of persons with disability:

Personal provision

Garant SP:
  • prof. Ing. Vladimír Wsól, Ph.D.
More details
Subject Area Board Members:
  • Chairman, Wsól Vladimír, prof. Ing., Ph.D. (from 25.4.2024)
  • Members, Bílková Zuzana, prof. RNDr., Ph.D. (from 2.10.2025)
  • Members, Boušová Iva, doc. PharmDr., Ph.D. (from 2.10.2025)
  • Members, Havelek Radim, doc. RNDr., Ph.D. (from 2.10.2025)
  • Members, Matoušková Petra, doc. Ing., Ph.D. (from 2.10.2025)
  • Members, Musílek Kamil, prof. PharmDr., Ph.D. (from 2.10.2025)
  • Members, Pejchal Jaroslav, doc. MUDr. Mgr., Ph.D. et Ph.D. (from 2.10.2025)
  • Members, Roušar Tomáš, doc. RNDr., Ph.D. (from 2.10.2025)
  • Members, Řezáčová Martina, prof. MUDr., Ph.D. (from 2.10.2025)
  • Members, Skálová Lenka, prof. RNDr., Ph.D. (from 2.10.2025)
  • Members, Soukup Ondřej, prof. PharmDr., Ph.D. (from 2.10.2025)
  • Members, Szotáková Barbora, prof. Ing., Ph.D. (from 2.10.2025)
  • Members, Šimůnek Tomáš, prof. PharmDr., Ph.D. (from 2.10.2025)

Instruction

Admission procedure requirements:
Study programme (branch) is open for applicants for the academic year 2026/2027:
Admission procedure requirements in the acaademic year 2025/2026:

Can be studied in combination

No combinations have been found